Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

81.75
-0.8800-1.06%
Post-market: 81.24-0.5100-0.62%17:14 EDT
Volume:12.84M
Turnover:1.06B
Market Cap:205.28B
PE:11.88
High:83.58
Open:82.91
Low:81.52
Close:82.63
Loading ...

Merck & Company: Strong Growth Potential and Favorable Risk/Return Profile Amidst Keytruda’s Performance and Diverse Portfolio

TIPRANKS
·
07 Jul

Top Dividend Stocks To Consider In July 2025

Simply Wall St.
·
05 Jul

US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy

Bloomberg
·
04 Jul

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Zacks
·
04 Jul

2 Soaring Stocks With More Upside Potential to Buy and Hold

Motley Fool
·
04 Jul

Merck & Co. Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
04 Jul

Merck's HPV Vaccine Gardasil Remains Key Driver Ahead of Q2 Results, UBS Says

MT Newswires Live
·
03 Jul

FDA Grants Priority Review for Merck's WINREVAIR™ Label Update Following Promising ZENITH Trial Results

Reuters
·
02 Jul

Berenberg Bank Reaffirms Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
02 Jul

Dow's 400-Point Rally Highlighted By Gains In Amgen, Merck, Sherwin-Williams, UnitedHealth and Nike Shares

Dow Jones
·
02 Jul

Merck Foundation Chairman, CEO, and 14 First Ladies Inaugurate the 7th Edition of Merck Foundation First Ladies Initiative - MFFLI Summit in Dubai

Business Wire
·
01 Jul

Merck & Co. Inc. to Hold Second-Quarter 2025 Sales and Earnings Conference Call

Reuters
·
01 Jul

SpringWorks Merger with Merck Approved by Shareholders

TIPRANKS
·
27 Jun

The Anti-Vax Movement Solidifies Control of the CDC's Vaccine Committee -- Barrons.com

Dow Jones
·
27 Jun

Merck's ENFLONSIA™ Receives Provisional Recommendation from CDC Advisory Committee for RSV Prevention in Infants, Awaits Final Approval

Reuters
·
27 Jun

US CDC panel broadly recommends flu shots free from thimerosal

Reuters
·
27 Jun

US CDC panel votes in favor of Merck's RSV antibody drug

Reuters
·
26 Jun

Medicenna Therapeutics Corp. Releases MD&A Report for Year Ended March 31, 2025

Reuters
·
26 Jun

2 Stocks Too Cheap to Ignore at These Prices

Motley Fool
·
26 Jun

FACTBOX-Vaccines and antibodies up for debate at CDC advisory panel meeting

Reuters
·
25 Jun